FedCircuitBlog

Here is an update on recent activity at the Supreme Court in cases decided by the Federal Circuit.

The Supreme Court received petitions for writ of certiorari in (1) Argentum Pharmaceuticals LLC v. Novartis Pharmaceuticals Corporation and (2) Nazir Khan, et al. v. Merit Medical Systems Inc.

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include a new petition by a pro se appellant and the denial of two petitions in cases raising questions related to standing and obviousness. Here are the details.

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include new petitions filed in three cases raising questions related to standing, obviousness, and eligibility; a new invitation for a response in a case raising questions related to obviousness; two new amicus briefs in cases raising questions related to claim construction, joinder, and deference to Precedential Opinion Panels; and the denial of seven petitions raising questions related to claim construction, eligibility, novelty, non-obviousness, and the Appointments Clause. Here are the details.

• Full Federal Circuit Will Consider Court Review of VA Rules – The Federal Circuit will consider whether it lacks jurisdiction to review interpretive rules in the VA’s administrative staff manual.
• CAFC Issues Another Precedential Decision on Standing – In a recent opinion, the Federal Circuit addressed standing requirements regarding IPRs.
• Federal Circuit Sinks Another Attempt to Use PTO Guidance – The Federal Circuit makes clear that it does not apply USPTO guidance when determining subject matter eligibility.

Here’s the latest.

This morning the Federal Circuit issued three opinions: one precedential opinion in a patent case; one precedential opinion in a tax case; and one nonprecedential opinion in a takings case. Here are the introductions to the opinions.